COMS

Conférences - Biologie - Canada

Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Les organisateurs peuvent soumettre une réunion ou une conférence pour inclusion dans nos listes, et ceci gratuitement.

Sélecionner un pays:
Allemagne (9) - Australie (1) - Autriche (3) - Canada (13) - Chine (1) - Corée du Sud (1) - Danemark (1) - Espagne (1) - Grèce (1) - Inde (4) - Irlande (2) - Italie (9) - Japon (1) - Royaume-Uni (7) - Russie (1) - République tchèque (1) - Singapour (1) - Suisse (2) - Suède (1) - Thaïlande (1) - Turquie (1) - États-Unis (66) - TOUS LES PAYS (128)

1.Keystone Symposia: Gene Silencing by Small RNAs
Dates	07 Fév 2012 → 12 Fév 2012	[ID=427736]
Lieu	Vancouver, British Columbia, Canada
Résumé	The impact of small non-coding RNAs has profoundly touched the fields of development and cell biology, functional genomics, human disease and drug therapy. This mode of gene regulation is not restricted to eukaryotes; bacteria utilize small RNAs, notably those made from CRISPR loci that silence the expression of bacteriophages, transposons and plasmids. There are still many gaps in our knowledge of the mechanisms used by small RNAs, particularly newly discovered RNAs. It has become clear that this field of study needs an annual forum to enable rapid dissemination of new discoveries between researchers. Overall, the goals of this proposed meeting are: (1) to foster the scientific development of junior investigators by promoting their interaction with established investigators, and (2) to allow for mixing and sharing of ideas between biochemists, molecular biologists, geneticists and systems biologists working in the field. We hope this will synergize ideas and method breakthroughs in small RNA mechanisms.
Sujets	Keystone Symposia, Gene Silencing, RNA, iRNA, Noncoding, Transcription, Translation, Expression, Chromatin Structure and Function, Molecular Biology
Page web	http://www.keystonesymposia.org/12B1
Sujets apparentés	Médecine (en général)

2.Keystone Symposia: Cancer and Metabolism
Dates	12 Fév 2012 → 17 Fév 2012	[ID=427722]
Lieu	Banff, Alberta, Canada
Résumé	Although altered glucose metabolism was first noted as a characteristic of tumor cells by Otto Warburg in the 1920s, the molecular underpinning for this observation did not begin to be appreciated fully until the past decade. This area has exploded over the last five years with the identification of extensive interactions of genuine tumor suppressor genes and oncogenes with metabolic control. The increased biosynthetic needs of tumor cells demand a reprogramming of cellular metabolism, which also creates increased energy demands and makes tumor cells more vulnerable to interventions targeting their metabolism. The goal of the Keystone Symposia meeting on Cancer and Metabolism is to bring together leaders in the fields of cancer and metabolic control with those studying the signaling pathways linking and governing each. The latest discoveries will be discussed as well as how this knowledge can be exploited to design future cancer therapeutics. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Advances in Hypoxic Signaling: From Bench to Bedside, which will share a keynote address and a plenary session with this meeting.
Sujets	Keystone Symposia, Cancer, Metabolism, Basic Mechanisms
Page web	http://www.keystonesymposia.org/12Q3
Sujets apparentés	Médecine (en général); Cancérologie

3.Keystone Symposia: Advances in Hypoxic Signaling: From Bench to Bedside
Dates	12 Fév 2012 → 17 Fév 2012	[ID=427765]
Lieu	Banff, Alberta, Canada
Résumé	Changes in tissue oxygen levels are frequently associated with pathological conditions such as pulmonary, cardiovascular and neoplastic diseases, but also occur physiologically during development. Recent advances in understanding the molecular basis of cellular and systemic hypoxia responses have led to the discovery of novel therapeutic targets that have the potential to impact the treatment of ischemic and neoplastic diseases. This Keystone Symposia meeting on Advances in Hypoxic Signaling: From Bench to Bedside will provide a state-of-the-art overview and critical discussion of hypoxia research and will serve as a superb platform for scientific exchange between senior and junior investigators, including students. This meeting brings together leading experts in the field of hypoxic signaling and will: 1) discuss the most recent advances in the regulation of cellular and systemic hypoxia responses; 2) examine the role of hypoxia response pathways in embryonic development, tumorigenesis, tissue injury and repair, inflammation and metabolism; and 3) highlight the latest developments in therapeutic targeting of hypoxia response pathways. This meeting aims to further our understanding of the biological response to hypoxia and promote use of this information for therapeutic gain. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Cancer and Metabolism, which will share a keynote address and a plenary session with this meeting.
Sujets	Keystone Symposia, Hypoxic Signaling, Hypoxic Signalling, Hypoxia, Organ Systems, Development, Metabolic Diseases, Biochemistry, Cardiovascular
Page web	http://www.keystonesymposia.org/12Q4
Sujets apparentés	Biochimie et chimie médicale; Médecine (en général)
4.Keystone Symposia: NF-kappaB Signaling and Biology: From Bench to Bedside
Dates	18 Mar 2012 → 23 Mar 2012	[ID=427851]
Lieu	Whistler, BC, Canada
Résumé	The regulation and function of NF-kB have captivated molecular and cellular biologists, as well as immunologists, pathologists and drug developers for many years. Studies of NF-kB and its regulation have taught us many fundamental lessons and principals in basic biological sciences as well as in biomedicine. Although rapidly reaching maturity, with 25 years since its discovery, the NF-kB field remains vibrant and fertile, and never ceases to amaze with new groundbreaking discoveries. The Keystone Symposia meeting on NF-kB Signaling and Biology: From Bench to Bedside will cover the basic biochemistry of NF-kB signaling; how NF-kkB accomplishes its main job as a transcription factor; the roles of the NF-kB system in immunity and inflammation; how NF-kB controls cell death, survival and metabolism; and how all of these functions go awry during disease development ? something that we have learned both from studies of genetically altered mice and from studies of human genetic defects and pathology. Finally, this meeting will teach us how we might fix and cure these problems through the pharmacological targeting of the NF-kB system. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Ubiquitin Signaling, which will share a keynote address and three plenary sessions with this meeting.
Sujets	Keystone Symposia, NF-êB, NF-kappaB, Signaling, Biology, Biochemistry, newly identified cofactors in linking different signaling pathways
Page web	http://www.keystonesymposia.org/12X1
Sujets apparentés	Médecine (en général); Biochimie et chimie médicale
5.Keystone Symposia: Ubiquitin Signaling
Dates	18 Mar 2012 → 23 Mar 2012	[ID=427916]
Lieu	Whistler, BC, Canada
Résumé	Post-translational modifications of cellular proteins by ubiquitin and ubiquitin-like modifiers regulate a variety of functions in the cell. A crucial aspect of signaling through ubiquitin and Ubls is the presence of modular binding domains that recognize particular types of ubiquitin signals. Such molecular coupling creates an attractive ?decoding? mechanism for responding to alterations in the cellular microenvironment and regulating physiological and pathophysiological conditions. In this meeting, we will discuss the major challenges in the field including detection of endogenous ubiquitination events, functional aspects of novel types of ubiquitin chains and their recognition by selective binding domains, and high-throughput technologies for comprehensive analysis of Ub modifications. The intersection between the deregulated ubiquitin signaling, pathogenesis of human diseases and therapies targeting the Ub system will be explored. The program offers a possibility for young scientists to present their own work and engage in discussions on the emerging topics in the field. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on NF-kB Signaling and Biology: From Bench to Bedside, which will share a keynote address and three plenary sessions with this meeting.
Sujets	Signaling, Inflammation, Immunology, Biochemistry, Keystone Symposia, Ubiquitin Signaling, NF-kappaB, NF-kB, Whistler, British Columbia, Canada
Page web	http://www.keystonesymposia.org/12X2
Sujets apparentés	Biochimie et chimie médicale; Médecine (en général)
6.Keystone Symposia: Mitochondrial Dynamics and Function
Dates	19 Mar 2012 → 24 Mar 2012	[ID=427947]
Lieu	Banff, AB, Canada
Résumé	Mitochondria are no longer considered ?only? as the cellular thermodynamic converter: mounting evidence implicates them as key organelles in cell signaling, proliferation, aging, disease and death. Indeed, our view of this organelle was profoundly altered with the discovery that mitochondria function within a connected network that is continuously remodeled by fusion and division events. This reality has sparked and accelerated new scientific discoveries through the intersection of different fields about the functional roles and molecular features of mitochondrial behaviors. The interaction between the cell death and mitochondrial dynamics fields is the best example of such interplay and has led to the discovery that modulators governing cell death and mitochondrial dynamics, respectively, are in fact interacting with one another. This Keystone Symposia meeting uniquely builds on this rich interdisciplinary interaction, which continues to provide novel insights into the mechanisms underlying mitochondrial behavior and mitochondrial-associated diseases. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Cell Death Pathways: Beyond Apoptosis, which will share a keynote address and two plenary sessions with this meeting.
Sujets	Keystone Symposia, Mitochondrial, Dynamics, Function, morphology, organelle, disease, autophagy, metabolism, cell biology
Page web	http://www.keystonesymposia.org/12X3
Sujets apparentés	Médecine (en général)
7.Keystone Symposia: Cell Death Pathways: Beyond Apoptosis
Dates	19 Mar 2012 → 24 Mar 2012	[ID=427891]
Lieu	Banff, AB, Canada
Résumé	Mounting evidence indicates that cell death in diseases results from complex interactions between molecular mechanisms taking place within the degenerating cells (cell-autonomous) and outside the degenerating cells (non-cell autonomous). At the cross roads of these diverse signaling pathways are found the mitochondria which, through proper mitochondrial dynamics and regulated mitochondrial elimination by autophagy (i.e., mitophagy), play a crucial role in maintaining the well-being of the cells. This meeting will focus on the general mechanisms of cell death including the Bcl-2 family and caspase proteases, the role of mitochondrial dynamics and mitophagy, the usefulness of bioinformatics to unravel death-pathways, the contribution of non-cell autonomous mechanisms to cell death and the therapeutic strategies to protect against cell death. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Mitochondrial Dynamics and Function, which will share a keynote address and two plenary sessions with this meeting.
Sujets	Keystone Symposia, Cell Death Pathways, Apoptosis, pathogenesis, tumor, immunology, Neurodegenerative Disease, Neurobiology, Signaling, Biochemistry, Basic mechanisms, cancer
Page web	http://www.keystonesymposia.org/12X4
Sujets apparentés	Biochimie et chimie médicale; Médecine (en général)
8.Keystone Symposia: Cell Biology of Virus Entry, Replication and Pathogenesis
Dates	26 Mar 2012 → 31 Mar 2012	[ID=427930]
Lieu	Whistler, BC, Canada
Résumé	This meeting will highlight recent advances in virus infection pathways, and in the cellular responses to viral infection. The meeting features multiple stages of the viral lifecycle analyzed using a broad array of techniques and levels of analysis. A novel feature of this meeting is that it will be held concurrently with the Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication and will, therefore, focus on maximizing exchange between the HIV community and the broader community of virologists. An explicit goal is to bring together and promote potential synergies among researchers who might not otherwise interact in more specialized meetings. A classic, almost paradigmatic, example of the power of this cross-talk is the contribution of studies of influenza A virus hemagglutinin to our understanding of the HIV-1 entry process, and the subsequent contribution of both systems to our understanding of type I fusion, type II fusion and the entry processes of non-enveloped viruses. Accordingly, two common sessions will focus on the retroviral entry process and its inhibition, followed by talks featuring a broader survey of viral entry, replication, structural and systems approaches to virology, host immune evasion and therapeutics.
Sujets	Keystone Symposia, Cell, Biology, Virus, Entry, Replication, Pathogenesis, virologists, viral, infectious diseases, membrane, proteins, antibodies, innate, immunity, biochemistry
Page web	http://www.keystonesymposia.org/12X7
Sujets apparentés	Biochimie et chimie médicale; Médecine (en général)
9.Keystone Symposia: Frontiers in HIV Pathogenesis, Therapy and Eradication
Dates	26 Mar 2012 → 31 Mar 2012	[ID=427995]
Lieu	Whistler, BC, Canada
Résumé	AIDS is incurable because cells latently infected with HIV resist antiviral therapy. Topical to the discussion of HIV eradication is the biology behind latent infection as well as models for the study of latency and pharmacological approaches to stimulate proviral gene expression. The Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication will create an environment for free exchange of ideas and cutting-edge results from a range of scientists in academia and industry in the fields of HIV pathogenesis, pharmacology and eradication. Joint plenary sessions with the concurrent meeting on Cell Biology of Virus Entry, Replication and Pathogenesis will highlight common topics of interest including mechanisms of virus entry and inhibition, and will significantly enhance opportunities for interdisciplinary interactions. Leaders from the HIV replication and drug resistance fields will critically examine the state of antiviral therapy, novel inhibitors and important virus-host interactions. Speakers selected from submitted abstracts will fill out workshops on pharmacological approaches and the cell biology of HIV infection.
Sujets	Keystone Symposia, HIV, Pathogenesis, Therapy, Eradication, drug, development, resistance, HAART, antitretroviral, infectious diseases
Page web	http://www.keystonesymposia.org/12X8
Sujets apparentés	Pharmacologie et développement des médicaments; Médecine (en général)
10.Keystone Symposia: Nuclear Receptor Matrix: Reloaded
Dates	15 Avr 2012 → 20 Avr 2012	[ID=428065]
Lieu	Whistler, BC, Canada
Résumé	Nuclear receptors (NRs) represent a large superfamily of transcription factors that function as ligand-dependent sensors for a diverse set of fat-soluble hormones, vitamins and dietary lipids. Together, NRs govern expression of genes involved in a broad range of reproductive, developmental, metabolic and immune response programs. For this reason, NRs have been investigated for over 20 years as promising targets for drugs to treat a multitude of therapeutic indices, including cancer, diabetes, obesity, cardiovascular disease, hypertension, inflammation and cholestasis. However, despite the success of numerous NR-based therapies, there remain significant hurdles exploiting NRs to develop newer classes of therapies that achieve targeted benefits with reduced side effects. Thus, understanding the mechanisms, transcriptional targets and networks of physiologic pathways that govern NR action has become an important new strategy for evaluating the role of NRs in health and disease. This ?reloaded? effort is now beginning to produce exciting new avenues of research in the field. This meeting will bring together a key group of junior and senior investigators that are exploring these new directions and provide participants with a matrix of unique possibilities for them to investigate in both academic and pharmaceutical laboratory settings.
Sujets	Keystone Symposia, Nuclear, Receptor, Matrix, nucleus, cell, biology
Page web	http://www.keystonesymposia.org/12D3
Sujets apparentés	Biologie moléculaire; Biochimie et chimie médicale
11.ASP 2012 — 36th Meeting of The American Society for Photobiology
Dates	23 Jui 2012 → 27 Jui 2012	[ID=445032]
Lieu	Montréal, Canada
Page web	http://www.pol-us.net/asp2012/ASP2012.pdf
12.ASP-2012 — 36th Meeting of the American Society for Photobiology
Dates	23 Jui 2012 → 28 Jui 2012	[ID=462569]
Lieu	Montreal, Canada
Résumé	Photobiology is the biological study of the interactions of light with living organisms. The ASP promotes research in photobiology, integration of different photobiology disciplines, dissemination of photobiology knowledge, and provides information on photobiological aspects of national and international issues.
Page web	http://www.asp2012.org
13.ICSB 2012 — International Conference on Systems Biology
Dates	19 Aou 2012 → 23 Aou 2012	[ID=453372]
Lieu	Toronto, Canada
Organisateur	Professor Charles Boone
Page web	http://icsb2012toronto.com/information.php
Contact	Ms Cynthia Colby, Donnelly Centre for Cellular and Biomolecular Research 100 College Street, Room 1306 Toronto M5S 3E1 Canada
Sujets apparentés	Bio-informatique

Canada: liste de tous les évènements/conférences.

Dernière mise à jour: 19 janvier 2012